Alynylam Pharmaceuticals (ALNY +3.3%) trades higher after the firm releases positive results...
Alynylam Pharmaceuticals (ALNY +3.3%) trades higher after the firm releases positive results from clinical tests of its cholesterol-reducing treatment. The firm says it will continue the study with increased dosages.
From other sites
at Zacks.com (Apr 9, 2015)
at Nasdaq.com (Mar 25, 2015)
at Zacks.com (Mar 13, 2015)
at Benzinga.com (Feb 27, 2015)
at Nasdaq.com (Jan 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs